Showing results (191-200 of 5,331) with videos related to
Sort By:
Pageof 534
European Journal of Cancer (Oxford, England : 1990)|July 3, 2024
CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harmsAlyson Haslam, Sruthi Ranganathan, Vinay Prasad, et al.JAMA Internal Medicine|November 9, 2020
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018Patrick C DeMartino, Miloš D Miljkovic, Vinay PrasadJAMA Network Open|February 1, 2023
Frequency and Characteristics of Trials Using Medical Writer Support in High-Impact Oncology JournalsEva Buck, Alyson Haslam, Jordan Tuia, et al.CMAJ Open|January 19, 2018
Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutesMichael J Hayes, Victoria Kaestner, Sham Mailankody, et al.Journal of Chromatography. A|April 24, 2022
Can a computer "learn" nonlinear chromatography?: Physics-based deep neural networks for simulation and optimization of chromatographic processesSai Gokul Subraveti, Zukui Li, Vinay Prasad, et al.European Journal of Cancer (Oxford, England : 1990)|September 21, 2020
Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?Derrick L Tao, Thomas Kartika, Audrey Tran, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncologyAlyson Haslam, Spencer P Hey, Jennifer Gill, et al.Bioresource Technology|April 5, 2015
In situ biodegradation of naphthenic acids in oil sands tailings pond water using indigenous algae-bacteria consortiumHamed Mahdavi, Vinay Prasad, Yang Liu, et al.Urology|April 27, 2016
Spontaneous Cystic Penile Vascular Malformation in an Adolescent and Review of the LiteratureJanae Preece, Vinay Prasad, Megan Schober, et al.International Journal of Cancer|February 19, 2022
Quality of biomarker defined subgroups in FDA approvals of PD-1/PD-L1 inhibitors 2014 to 2020Myung S Kim, Alexander Xu, Alyson Haslam, et al.Pageof 534